The role of inhibitor of binding or differentiation 2 in the development and differentiation of immune cells

Immunobiology. 2019 Jan;224(1):142-146. doi: 10.1016/j.imbio.2018.09.006. Epub 2018 Sep 20.

Abstract

Inhibitor of binding or differentiation 2 (Id2), a member of helix-loop-helix (HLH) transcriptional factors, is recently reported as an important regulator of the development or differentiation of immune cells. It has been demonstrated that Id2 plays a critical role in the early lymphopoiesis. However, it has been discovered recently that Id2 displays new functions in different immune cells. In the adaptive immune cells, Id2 is required for determining T-cell subsets and B cells. In addition, Id2 is also involved in the development of innate immune cells, including dendritic cells (DCs), natural killer (NK) cells, and other innate lymphoid cells (ILCs). Here, we review the current reports about the role of Id2 in the development or differentiation of main immune cells.

Keywords: B cell; Dendritic cell; Inhibitor of binding or differentiation 2; Innate lymphoid cell; T cell.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adaptive Immunity
  • Animals
  • B-Lymphocytes / physiology*
  • Cell Differentiation
  • Dendritic Cells / physiology*
  • Humans
  • Immunity, Innate
  • Inhibitor of Differentiation Protein 2 / genetics
  • Inhibitor of Differentiation Protein 2 / metabolism*
  • Killer Cells, Natural / immunology*
  • T-Lymphocytes / physiology*

Substances

  • ID2 protein, human
  • Inhibitor of Differentiation Protein 2